Immediate Impact
60 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Mohammed Ibrahim being referenced
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mohammed Ibrahim | 278 | 110 | 45 | 76 | 39 | 436 | |
| Lixiang Yu | 220 | 101 | 69 | 34 | 41 | 491 | |
| Patrick Cobb | 290 | 101 | 41 | 29 | 43 | 453 | |
| Kiley Wei-Jen Loh | 236 | 150 | 50 | 47 | 32 | 481 | |
| B. Melosky | 206 | 137 | 41 | 30 | 22 | 424 | |
| Sina Vatandoust | 309 | 116 | 103 | 80 | 35 | 502 | |
| Kunal C. Kadakia | 190 | 85 | 46 | 85 | 43 | 426 | |
| Lucia Vassalli | 218 | 149 | 60 | 41 | 30 | 408 | |
| Carmel Jacobs | 255 | 84 | 64 | 87 | 31 | 466 | |
| Joachim Kieschke | 193 | 115 | 57 | 116 | 30 | 442 | |
| Alessandro De Luca | 190 | 66 | 118 | 109 | 44 | 492 |
All Works
Login with ORCID to disown or claim papers
Loading papers...